Tate & Lyle - Analyst consensus and earnings outlook in focus
Published on 06/20/2026 at 11:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Edited by ad hoc news Long-Term & Business-Model Desk. Verified prior to publication on 06/20/2026, 11:45 CET. Details in the imprint.
Tate & Lyle (GB0008707753) is drawing investor attention with its specialty ingredients profile and a cautious earnings outlook across recent analyst updates. Several consensus snapshots point to only modest revenue growth but ongoing portfolio reshaping in the medium term.
Background and price data on Tate & Lyle stock
Key figures, company news and historical data help frame Tate & Lyle’s valuation and earnings power in the specialty food ingredients market.
What recent estimates signal
Analyst aggregators show that expectations for Tate & Lyle’s current financial year remain muted, with low single-digit percentage revenue growth anticipated and only gradual margin progress.
One recent earnings preview for the group’s US-listed ADR, TATYY, highlighted a forecast earnings per share level of around $0.84 for an upcoming period alongside revenue near $1.29 billion, underlining a constrained profit backdrop.
How the long-term story is framed
Against this backdrop, many market observers frame Tate & Lyle primarily as a long-term specialty food ingredients player rather than a pure volume sugar business, emphasizing recurring demand from large consumer-goods customers.
The group has spent recent years reshaping its portfolio around higher-margin solutions such as texturants and sugar-reduction ingredients, while stepping back from bulk commodities to lift returns over a multi-year horizon.
How the company makes money
Tate & Lyle generates most of its revenue by supplying specialty food and beverage ingredients like sweeteners, fiber-enrichment solutions and texturants to global manufacturers, focusing on reformulation trends such as sugar reduction and improved nutritional profiles.
Where the stock trades today
The shares of Tate & Lyle (GB0008707753) trade in London on the LSE; a precise, up-to-the-minute quote could not be reliably verified at the time of editing.
Key facts on Tate & Lyle stock
- Company: Tate & Lyle PLC
- ISIN: GB0008707753
- Ticker: TATE
- Venue: London Stock Exchange
- Sector / Industry: Consumer Staples / Packaged Foods & Ingredients
- Index membership: FTSE 250
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
